AbbVie, Inc. (ABBV)
218.06
-3.83
(-1.73%)
USD |
NYSE |
Jan 15, 13:07
AbbVie SG&A Expense (TTM): 13.97B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.976B |
| Gilead Sciences, Inc. | 5.886B |
| Johnson & Johnson | 23.38B |
| Eli Lilly & Co. | 10.39B |
| Merck & Co., Inc. | 10.70B |